Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Blood|May 31, 2002
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphomaRosita L ten Berge, Chris J L M Meijer, Danny F Dukers, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cancer Research|February 12, 2011
Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cellsMarvin M van Luijn, Willemijn van den Ancker, Martine E D Chamuleau, et al.
Immunotherapy|July 20, 2010
Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemiaWillemijn van den Ancker, Marvin M van Luijn, Theresia M Westers, et al.
Plos One|November 19, 2013
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cellsGerrit J Schuurhuis, Michael H Meel, Floris Wouters, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2010
Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturationWillemijn van den Ancker, Marvin M van Luijn, Jurjen M Ruben, et al.
Plos One|September 23, 2014
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemiaMonique Terwijn, Wendelien Zeijlemaker, Angèle Kelder, et al.
Cancer Research|August 18, 2004
Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcomeMartine E D Chamuleau, Yuri Souwer, S Marieke Van Ham, et al.
Blood Advances|December 5, 2024
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AMLChristian M Vonk, Tim Grob, Melissa Rijken, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Blood|May 31, 2002
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphomaRosita L ten Berge, Chris J L M Meijer, Danny F Dukers, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cancer Research|February 12, 2011
Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cellsMarvin M van Luijn, Willemijn van den Ancker, Martine E D Chamuleau, et al.
Immunotherapy|July 20, 2010
Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemiaWillemijn van den Ancker, Marvin M van Luijn, Theresia M Westers, et al.
Plos One|November 19, 2013
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cellsGerrit J Schuurhuis, Michael H Meel, Floris Wouters, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2014
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromesCanan Alhan, Theresia M Westers, Lieke H van der Helm, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2010
Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturationWillemijn van den Ancker, Marvin M van Luijn, Jurjen M Ruben, et al.
Plos One|September 23, 2014
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemiaMonique Terwijn, Wendelien Zeijlemaker, Angèle Kelder, et al.
Cancer Research|August 18, 2004
Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcomeMartine E D Chamuleau, Yuri Souwer, S Marieke Van Ham, et al.
Blood Advances|December 5, 2024
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AMLChristian M Vonk, Tim Grob, Melissa Rijken, et al.
Pageof 20